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Abstract
Helicobacter pylori is a Gram-negative bacterium that causes gastric and duodenal diseases in humans. Despite a robust
antibody and cellular immune response, H. pylori infection persists chronically. To understand if and how H. pylori could
modulate T cell activation, in the present study we investigated in vitro the interaction between H. pylori and human T
lymphocytes freshly isolated from peripheral blood of H. pylori-negative donors. A direct interaction of live, but not killed
bacteria with purified CD3+ T lymphocytes was observed by microscopy and confirmed by flow cytometry. Live H. pylori
activated CD3+ T lymphocytes and predominantly cd+ T cells bearing the TCR chain Vd2. Upon interaction with H. pylori,
these cells up-regulated the activation molecule CD69 and produced cytokines (such as TNFa, IFNc) and chemokines (such
as MIP-1b, RANTES) in a non-antigen-specific manner. This activation required viable H. pylori and was not exhibited by
other Gram-negative bacteria. The cytotoxin-associated antigen-A (CagA), was at least partially responsible of this activation.
Our results suggest that H. pylori can directly interact with T cells and modulate the response of cd+ T cells, thereby
favouring an inflammatory environment which can contribute to the chronic persistence of the bacteria and eventually to
the gastric pathology.
Citation: Romi B, Soldaini E, Pancotto L, Castellino F, Del Giudice G, et al. (2011) Helicobacter pylori Induces Activation of Human Peripheral cd+ T
Lymphocytes. PLoS ONE 6(4): e19324. doi:10.1371/journal.pone.0019324
Editor: Niyaz Ahmed, University of Hyderabad, India
Received January 13, 2011; Accepted March 25, 2011; Published April 29, 2011
Copyright:  2011 Romi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These authors have no support or funding to report.
Competing Interests: Benedetta Romi performed this study at Novartis Vaccines and Diagnostics within the frame of her PhD at the University of Novara, Italy.
Elisabetta Soldaini, Laura Pancotto, Flora Castellino, Giuseppe Del Giudice and Francesca Schiavetti are full-time employees of Novartis Vaccines and Diagnostics,
Siena. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: francesca.schiavetti@novartis.com
Introduction
Helicobacter pylori (H. pylori) is a spiral shaped Gram-negative
bacterium that causes gastric and duodenal disorders. The H. pylori
infection is typically acquired in early childhood via person-to-
person spread, via oral-oral or fecal-oral transmission. The
majority of infected individuals remain asymptomatic, and only
a 5–15% develops serious complications. Chronic infection with
Helicobacter pylori is the major known risk factor for duodenal and
gastric ulcer diseases and cancer [1,2], which are frequently
associated with the expression of CagA antigen [3,4,5].
Helicobacter pylori infection induces a strong local immune
response with infiltration of the mucosa by neutrophils, macro-
phages and lymphocytes. Many studies reported that the T cell
response to H. pylori is prevalently of Th1 type with infiltration of
IFN-c producing T cells in the site of infection [6]. In addition,
unconventional T cell populations may also intervene at the
mucosal level in response to H. pylori stimuli and modulate the
outcome of the infection, leading to local inflammation, chronic
persistence of lesions and eventually cancer [1]. Some studies have
described the involvement of cd+ T cells in Helicobacter pylori
gastritis [7,8,9]. In particular, one study has reported the
infiltration of cd+ T cells in H. pylori infected biopsies that were
significantly higher in grade III gastritis while strongly decreased
after eradication therapy [10]. Moreover cd+ T cells appear to
have both pro-inflammatory and regulatory functions: they can act
as a bridge between innate and adaptive immunity early in the
response and down-modulate inflammation once the infection is
cleared [7].
In the present study we investigated the interaction of H. pylori
with human T cell populations, including cd+ T cells and how this
interaction modulated their state of activation and ability to
produce cytokines.
Results
H. pylori directly interacts with T lymphocytes
To investigate whether H. pylori physically interacted with
human T cells, T lymphocytes were purified from peripheral
blood of H. pylori negative donors and co-cultured with viable G27
H. pylori strain. After 4 h of culture cell clustering was visible
microscopically suggesting a direct interaction between T
lymphocytes and the live bacteria (Figure 1B). In contrast,
formaldehyde fixed H. pylori were unable to exert the same effect
(Figure 1C). Lymphocyte activation was also evident by cyto-
fluorimetric analysis because of an increase of cellular complexity
(side scatter) of T cells cultured with bacteria, as compared to
unstimulated control (data not shown).
To ascertain whether the T cell clustering was due to a direct
interaction of the bacteria with purified T lymphocytes, co-
cultures were also examined by confocal microscopy, using GFP-
transfected H. pylori. As shown in Figure 2A, green fluorescent
bacteria were tightly surrounding most of the purified T cells. In
addition, we assessed by flow cytometry the percentage of purified
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compared to the control (Figure 2A), about 80% of CD3+cells had
fluorescent bacteria bound to them (Figure 2B). Interestingly, this
interaction was nearly absent if the bacteria were treated with
formaldehyde (Figure 2C). Taken altogether these data strongly
suggest that the bacteria directly interacted with T cells and that
this interaction required viable H. pylori.
H. pylori activation of purified T lymphocytes in short
term co-cultures
To investigate if the observed interaction also modulated the
function of T lymphocytes, purified CD3+ cells were co-cultured
with viable H. pylori, using fixed bacteria as a control, to assess the
up-regulation of CD69, known to be an early activation marker
antigen of lymphocytes. Figure 3 shows that CD69 was
significantly up-regulated by CD3+ cells co-cultured with live
bacteria, but not with killed bacteria. These data show that H.
pylori driven T lymphocytes activation occurred in the absence of
APCs, and suggest that this effect was independent of their antigen
specificity. Moreover, we also found that the T cell responsiveness
was not increased when we used PBMCs from H. pylori positive
subjects (supplementary materials Figure S1). This suggests that
the activation mechanism is not antigen-specific, and it does not
depend on previous infections with H. pylori.
The ability to induce up-regulation of CD69 on CD3+ cells was
also evaluated using a mutant of H. pylori G27 unable to synthesize
CagA (DCagA). It is well known that CagA is translocated into
gastric epithelial cells causing changes in cell structure, function
and morphology [11]. The CD69 up-regulation was partially
reduced when cells were co-cultured with the bacteria lacking
CagA, as compared to wild type bacteria (average of 42% of
reduction). In conclusion, bacterial viability, rather than integrity
is required for CD3+ lymphocytes activation, with CagA being
partially involved in this process.
H. pylori induced cytokine production by T cells in the
absence of APCs
Subsequently we evaluated whether this activation of CD3+
cells after co-culture with H. pylori was accompanied by
production of cytokines/chemokines in the supernatants. Indeed,
H. pylori induced the production of cytokines such as TNFa,
IFNc and chemokines such as MIP1-b, Rantes by CD3+cells.
Very low levels of IL-2 were detected; moreover IL-6 was
undetactable, indicating that our system was highly purified from
APCs. Note that IL-6 was detectable at high levels when
unfractionated PBMCs were stimulated with live H. pylori (for IL-
6: medium =33626 pg/ml versus live H. pylori =13386
421 pg/ml). This effect was measurable already after 4 hours
(Table 1), and increased during overnight stimulation. Produc-
tion of cytokines and chemokines was confirmed by intracellular
staining, after stimulation of purified CD3+ cells for 16 h with
viable H. pylori. In addition, CD3+ T lymphocytes did not
Figure 1. H. pylori and T cells co-culture. Viable, but not fixed H. pylori cause T cells clustering after 4 h of co-culture. Light microscopy of purified
CD3+ cells after 4 h of culture without (A) or with (B) viable H. pylori or formaldehyde fixed H. pylori (C) (MOI 100).
doi:10.1371/journal.pone.0019324.g001
Figure 2. H. pylori-GFP and T cells interaction. Interaction of purified human CD3+ T lymphocytes with H. pylori-GFP was observed by confocal
microscopy (A) after 4 h of co-culture with viable H. pylori (MOI 100). T cell nuclei were labeled with DAPI (blue), while green fluorescence belongs to
GFP-H. pylori. The interaction between T cells and H. pylori was observed by FACS analysis (B). The gating was made on live CD3+ cells stained with
anti-CD3 A-700 m Ab. The number indicated in the dot plot represents the percentage of CD3+ cells that co-stained with H.pylori-GFP. The
histograms in panel C show the percentage of CD3+ cells that were stained with live (blue line) and fixed (green line) bacterium, compared with
unstimulated cells (red line).
doi:10.1371/journal.pone.0019324.g002
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PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e19324Figure 3. CD3+ T cells activation. Viable H. pylori activate purified human peripheral CD3+ T cells in vitro in a non-antigen-specific fashion.
Purified CD3+ cells were co-cultured with H. pylori (MOI 100). After 18 h cells were stained with anti CD3-PB and anti-CD69-APC. Numbers represent
the percentage of CD3+CD69+ cells. The difference in CD69 expression in the presence of wild-type H. pylori or of the DCagA strain (E) was
investigated in 15 independent experiments, and was statistically significant (***: P#0.0001).
doi:10.1371/journal.pone.0019324.g003
Table 1. CD3+ cells produce cytokines and chemokines after 4 hours of co-culture with H. pylori.
Medium + H. pylori wt + H. pylori D CagA
pg/ml Average (Range) Average (Range) P value Average (Range) P value
(medium vs H. pylori wt) (H. pylori wt vs DcagA)
IFN-c 12.1 (1.52–27.59) 307.4* (40.74–641.61) 0.049 161.4* (29.74–367.32) 0.030
TNF-a 6.0 (5.31–16.26) 476.5* (88.46–882.42) 0.025 344.9* (47.72–717) 0.020
Rantes 15.8 (4.7–27.02) 150.9 (42.27–265.89) 0.090 97.5 (16.43–184.7) 0.050
MIP-1b 21.7 (4.25–54.16) 968.1* (343–1600) 0.026 392.7* (184.58–901) 0.100
IL-2 3.3 (0.33–6.62) 8.1* (6.41–13.42) 0.030 4.2* (2.585–7.71) 0.030
IL-8 1.4 (1.84–0.98) 20.1 (14.66–36.12) 0.11 12.5 (6.62–29.65) 0.25
IL-10 n.d (,1.3 pg/ml) n.d (,1.3 pg/ml) n.a. n.d (,1.3 pg/ml) n.a.
IL-6 n.d (,1.4 pg/ml) n.d (,1.4 pg/ml) n.a. n.d (,1.4 pg/ml) n.a.
IL-17 2.2 (1.31–6.7) 7.3 (1.31–10.47) 0.22 5.4 (1.36–8.86) 0.26
Purified CD3+ cells from peripheral blood of H. pylori negative donors produce a wide range of cytokines and chemokines after 4 h of culture with H. pylori. Culture
supernatants was collected and analyzed by bioplex assay. Data represent the mean and the range of cytokines and chemokines produced by T cells. Statistical
significances of the differences between the cytokines production of CD3+/H. pylori co-culture compared to the control group (medium) were assessed using paired t
test and reported in the third column. The differences in cytokines production in presence of H. pylori wt and DCagA were also calculated and compared, as reported in
the last column of Table 1. The average was calculated from four independent experiments. Statistical significance was determined by Student’s paired T-test at
*: P#0.05. Note: n.d = not detectable. n.a=not applicable.
doi:10.1371/journal.pone.0019324.t001
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not shown).
To evaluate whether this effect was specific of H. pylori or it was
shared by other Gram-negative bacteria, some experiments were
carried out with Escherichia coli. Unlike H. pylori, E.coli was unable to
induce cytokines production by CD3+ T cells (Figure 4), nor
CD69 up-regulation (not shown) suggesting that this stimulatory
effect was peculiar of H. pylori, and not shared with other Gram-
negative bacteria.
H. pylori induced up-regulation of CD69 and cytokines
production by cd+ T cells in the absence of APCs
WethenaskedwhichCD3+T cells populations were preferentially
activated by H. pylori. We observed that the majority of CD3+
producing cytokines were CD3+CD4-CD8- double negative.
Therefore we asked whether, among these cells, cd+ T cells were
preferentially activated. We found that 30–60% of CD3+CD4-CD8-
T cells were TCR cd+ and 10% of total cd+ T cells produced TNFa
and IFNc after co-culture with the bacteria (Figure 5). These cd+ T
cells also produced the chemokines MIP1-b and Rantes and about
90% of them up-regulated the activation marker CD69 (data not
shown).It isworth ofnotethat theactivationofcd+Tce ll sbyH. pylori
clearly was independent on professional APCs, indicating that the
mechanism was not antigen specific.
In order to better characterize the phenotype of cd+ T cells
principally involved in the response to H. pylori, we evaluated the
contribution of the Vd2+ T cell subset. This subset of cd+ T cells
has been frequently reported to play a role in immunity against
bacterial, parasitic pathogens and tumors [12]. We found that the
majority of cytokine secreting CD3+T cells after co-culture with
H. pylori were Vd2+ (Figure 6). In addition DCagA was still able to
induce T lymphocytes activation, although at a level lower than H.
pylori wild type. Finally, no cytokine production was observed after
stimulation of cd T cells with purified bacterial protein CagA (not
shown), indicating that active processes mediated by H. pylori were
required to achieve the highest activation of T cells and suggesting
that CagA had to be actively translocated into the cells to exert its
effect.
Discussion
In this study we show that H. pylori is able to stimulate peripheral
blood T lymphocytes from H. pylori negative donors without the
need forAPCs. Thefact that thiseffecthappens onH.pylorinegative
subjects supports the idea that the stimulation is not antigen specific.
This activation requires direct contact between viable bacteria and
T cells, suggesting that the binding to the T cell membrane is
necessary with a metabolically active bacterium. In particular, we
Figure 4. CD3+ T cells and E.coli co-culture. H. pylori activate CD3+ T cells in a non-antigen-specific fashion after 16 hours of co-culture by
inducing cytokines production such as TNFa (A) and IFNc (B). E.coli was not able to exert the same stimulatory effect. Data are representative of three
independent experiments with similar results. The numbers in each panel represent the percentage of TNFa and IFNc-producing CD3+ cells.
doi:10.1371/journal.pone.0019324.g004
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T cells. Indeed after only 4 hours of co-culture these cells showed
significant up-regulation of the activation molecule CD69 and
release of a wide range of cytokines (such as TNFa, IFNc)a n d
chemokines (such as MIP-1b, RANTES). Moreover, the majority of
cd+ T cells producing cytokines expressed the Vd2 TCR chain.
Vd2+ subset is reported to be involved in the response against a
wide range of pathogens [8,13] although there is still much to
understand about the fine antigenspecificity of these cells, especially
in the context of H. pylori recognition.
Our findings that H. pylori is able to induce activation of T cells
are consistent with a previous report [14] describing murine CD4+
T cell clones that were activated by the bacteria in the absence of
APC. However in our study cells activated after contact with
bacteria were essentially CD3+CD4-CD8- cd+ Tcells. This could
be explained by the fact that we stimulated freshly isolated human
peripheral blood instead of differentiated Th1 and Th2 murine
clones. As suggested by the authors, terminally differentiated Th1
and Th2 murine cells could express receptors that allow activation
by H. pylori [14]. Remain to clarify if also in human the CD4+ T
cells after maturation could become more responsive to the H.
pylori activation, although available evidence with human CD4+ T
cell clones does not appear to support the murine data [6].
Since H. pylori resides at the apical side of the epithelial layer of
the gastric mucosa, one can raise the question on how viable
bacteria (and not just bacterial antigens) can interact with lymphoid
cells. The interaction between H. pylori and T cells can occur after a
damage of the epithelium cell layer during infection. The tissue
injury can be mediated by the release of many bacterial products,
such as the vacuolating toxin VacA, that is able to alter tight
junctions, increasing permeability [15] or CagA, which is actively
injected into the epithelial cells where it is responsible for the
alteration of epithelial cell morphology [16] or via factors
intervening at the basolateral side of the epithelium, such as
reactive oxygen intermediates induced by bacterial products
secreted or released after autolysis [17]. The damage of the gastric
barrier may lead to infiltration of H. pylori in the sub-mucosa,
generating an inflammatory status with infiltration of mononuclear
cells [18,19]. The activation of cd+ T cells that we observed after in
vitro stimulation with live H. pylori suggests that in vivo these cells may
recognize and interact directly with the bacteria infiltrating the
lamina propria. It has been reported that Vd2+ cells which are also
found in the intestinal epithelium, might contribute to the epithelial
homeostasis and might play an important role during the early stage
of the immune response against pathogens [12]. Furthermore, some
studies have reported an accumulation of cd+ T cells in the gastric
mucosa of H. pylori infected subjects that seem to correlate with the
severity of gastritis and infiltration of inflammatory cytokines [10].
In the present study we demonstrate, for the first time, that the
activation of cd+ T cells requires viable H. pylori and in particular
Figure 5. cd+ T cells activation. cd+ T cells produce cytokines after co-culture with live H. pylori (right panels). Purified CD3+ cells were co-cultured
for 18 h with viable bacteria at MOI 100. The first dot plot represents purified CD3+ cells, then dissected into CD4-8- and CD4+ and/or CD8+.
doi:10.1371/journal.pone.0019324.g005
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effect.
A wide variety of molecules have been described being able to
activate Vd2+ T cells [12,20,21]. Among these, there are small
compounds (like alkylamines and phosphoantigens) derived from
stress-associated surface molecules as well as small bacterial
metabolites or microbial compounds produced during infection
and cellular stress. The activation of cd T cells by bacterial
metabolites has been demonstrated in several studies using bacterial
extract and supernatants containing purified antigens [20,22].
However, in our experimental conditions we found that H. pylori
viability is necessary to induce the activation and requires whole
bacterium/cell contact. Therefore this leads us to speculate that
phosphoantigens or alkylamines are not the major components
responsible for this process. Moreover recent reports have shown a
functional expression of TLR 2, 3, 5 and 6 in freshly isolated blood
Vd2+ cells [23,24]. This may suggest that PAMPs, expressed on
Gram-negative bacteria surface, could be the putative molecules
that activate cd+ T cells in our in vitro system. However, the fact that
live E.coli or killed H. pylori are unable to exert this stimulatory effect
tends to rule out an involvement of TLRs agonists in this activation
process. Nevertheless, these observations do not exclude the
possibility of a partial involvement of TLR agonists as co-receptors.
According to that recent studies reported that TCR cross-linking is
required for TLR-mediated costimulatory effects on human cd T
cells activation and expansion [25,26].
Our data support the notion that other H. pylori specific
components must intervene in the cd+ T cells activation, which
are produced by metabolically active bacteria. CagA represents an
ideal candidate, since it is actively inoculated by the bacterium into
the epithelial cells via its type IV secretion system [16,27,28]. We
have shown that the activation of cd+ T cells by live bacteria is
reduced when cells are co-cultured with bacteria lacking CagA. In
the present study the activation of cd+ T cells require live CagA
positive bacteria but it was not observed after stimulation with the
purified CagA protein alone, suggesting the need for metabolically
active bacteria able to mediate translocation of CagA into the
lymphocytes. In agreement with the idea that the protein CagA
may be internalized by the lymphocytes, as it happens with
epithelial cells, we observed by flow cytometry a change in the
cellular complexity (Side Scatter) after bacterium-T cell interaction
that was nearly absent when T cells were cultured with the strain
lacking CagA. The importance of bacterium viability is supported
by the fact that treatments leading to kill H. pylori, such as
formaldehyde fixation, neutralize its stimulatory abilities. On the
contrary, the stimulatory activity is not altered after irradiation
Figure 6. Vcd2+ cells activation. Among cd+ cells, Vd2+ cells are those preferentially activated following co-culture of CD3+ T cells with viable H.
pylori. Purified CD3+ cells co-cultured with viable H. pylori wild type or the DCagA mutant at MOI 100 for 18 h. Dot plots are gated on CD3+/cd+ T
cells. Data are representative of three independent experiments with similar results. The numbers in each panel represent the percentage of TNFa
and MIP-1b producing cd+ cells, gated on CD3+ cells.
doi:10.1371/journal.pone.0019324.g006
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retaining its vital function. CagA, however, cannot be the only
responsible for cd+ T cells activation, since DCagA strains retain
their stimulatory ability. Several other factors, such as H. pylori type
IV organelle, which are not well characterized, could contribute to
the H. pylori stimulatory ability [29,30]. Thus, it is likely that
contact-dependent secretion of one or more factors transported by
the type IV apparatus could actively promote cd+ T cells
activation. Further experiments will be necessary to better clarify
all the molecular mechanisms that lie behind H. pylori/cd T cells
interaction. Note that experiments of stimulation with VacA-
knockout H. pylori mutant strain showed that the stimulatory
ability of the bacteria was retained even in the absence of VacA
(supplementary materials Figure S2).
Our results on the in vitro H. pylori activation of cd+ T cells after
short time interaction leads us to speculate that the bacteria could
take advantage formthis activation, by creating an environment that
prevents the complete clearance of the pathogen. In fact, despite the
strong immunological response, the pathogen is rarely eliminated
and, in the absence of treatment, infection can persists for life.
Previous studies have reported that chronic phase of inflammation is
also characterized by the concomitant presence of regulatory T cells
at the infection site can contribute to H. pylori persistence by
suppressing antibacterial responses [31]. According to this, we
observed that the direct contact of H. pylori with T lymphocytes
activates T cells and in particular cd+ T cells to produce CCR5
agonists(such asMIP1-b) that could participate inthe recruitment of
Tregs at the site of infection, where they may start to exert their
suppressive functions. Moreover it has been hypothesized that the
Tregs cell homing in sites of infection may be driven by the
chemokine receptor CCR5 that is described to be preferentially
expressedbyTregscomparedwithnormalCD4+Tcells[32].Inthis
frame we could speculate that the bacterium activates cd+ T cells to
produce chemokines that may positively control the recruitment of
regulatory T cells to the sites of gastric lesions.
Overall our findings showed that H. pylori can actively modulate
the function of CD3+cells and particularly cd+ T cells. This
activation may turn out to play a role in the maintenance of the
local inflammation and eventually to the gastric and duodenal
diseases.
Materials and Methods
Cell isolation and culture
Buffy coats were obtained from blood of donors serologically
negative for H. pylori. PBMC were separated by Ficoll density
centrifugation (Ge Healthcare, Little Chalfont, United Kingdom).
The PBMC layer was recovered, washed and then resuspended in
RPMI 1640 complete medium, (RPMI 1640 supplemented with
L-glutamine and 25 mM HEPES, containing 5% Human Serum
(Celbio, Milan, Italy) or 2% of FBS (HyClone South, Logan, UT).
For the co-culture experiments with H. pylori, PBMCs were
seeded in 96-well flat-bottom plates at a density of 2610
6 cells/
well. In all tests performed, T cells viability was assessed over time
using flow cytometric analysis and was comparable to that of
unstimulated cells.
CD3+ T cells were isolated from PBMCs by magnetic cell
separation using the Dynabeads Cell Isolation kits (Invitrogen, San
Diego, CA). The purity of cell preparations was confirmed by flow
cytometry and was found to be greater than 98%. Some
experiments were performed with sorted CD3+, CD3+CD4+,
CD3+CD8+, CD3+CD4-CD8- cells using FACSAria cell sorter
(BD, Becton, Dickinson Franklin Lakes, NJ). The yield of
purification, confirmed by FACS, was greater than 99%. In
addition, in some experiments we also used CD14 marker (BD,
Becton, Dickinson Franklin Lakes, NJ) to ascertain that our cell
preparation did not contain CD14+ cells following magnetic
separation and/or cell sorting.
Culture and preparation of H. pylori
H. pylori strain G27 and H. pylori G27 lacking the CagA gene
(DCagA) and the VacA gene (DVacA) have been extensively
previously described [33,34,35,36].
Bacteria were cultured microaerobically, using Campygen gas
generating system (Oxoid, Cambridge, UK) for 12 hours at 37uC,
on solid media consisting of Tryptic (trypticase) Soy Agar (TSA)
plates containing 5% FBS and H. pylori selective Agar (DENT),
supplemented with 200 mg/ml of kanamycin for the growth of
kanamycin-resistant mutants. Bacteria harvested from the plates,
were used to inoculate liquid cultures starting from an A535 of 0.2
in 15 ml of BHI supplemented with 5%FBS and DENT (+/2
Kanamycin) and grown at 37uC in microaerophilic conditions
with vigorous shaking (180 rpm) to an A535 of 0.5. Bacteria were
finally resuspended with BHI and 10 ml of bacteria suspension
were added to T cells suspension in order to obtain a multiplicity
of infection (MOI) of 100. After 14 h at 37uC under 5% CO2
humidified atmosphere, cultures were observed with an optical
microscope (Leica, Wetzlar, Germany) with 10x lents. For the
formaldehyde fixation, bacteria from liquid culture were incubated
in 2% formaldehyde in PBS for 30 min at room temperature and
washed four times in PBS. For peptidase digestion, bacteria were
incubated for 2.5 hours with proteinase K (Sigma-Aldrich,
Taufkirchen, Germany) at final concentration of 2.5 mg/ml.
Irradiated H. pylori were obtained treating 10
9 bacteria/ml of
PBS at 6000 rad and then washed and resuspended at the working
concentration.
Confocal microscopy
Interaction between cells and H. pylori was investigated using
Kanamycin, GFP transfected H. pylori G27 strain [37,38],
provided by Dr Stefano Censini (Novartis Vaccines and
Diagnostics, Siena, Italy).
Interaction between GFP-bacteria and T cells was imaged by
Zeiss Observer LSM 710 confocal microscope. DAPI staining was
used to determine the number of nuclei and to assess gross T cells
morphology. Laser lines at 405 nm, 488 nm were used for
excitation of DAPI and GFP respectively.
Analysis of activation markers and cytokines production
by Flow cytometry (FACS)
T cell response was assessed by stimulating purified T cell
populations with viable bacteria for 18 hours. Brefeldin (BFA, BD
Biosciences, Franklin Lakes, NJ) was added after 2 hours in order
to block proteins secretion. PBMC cultures in medium alone were
included as negative control.
Cells were stained with the LIVE/DEAD aqua viability marker
(Invitrogen), incubated with surface antibodies anti-CD69, fixed
and permeabilized with the cytofix/cytoperm kit (BD Biosciences)
and incubated with antibodies specific for CD3, CD4, CD8, IL-2,
IFNc, TNFa,V cd,V d2 TCR (all from BD Pharmingen, San
Diego, CA) conjugated with indicated fluorochromes.
Samples were acquired with a FACS LSRII (BD Bioscience)
and analyzed using Flowjo analysis software.
Cytokine secretion
Culture supernatants were harvested after 4 and 16 hours of H.
pylori/purified T cells co-culture and stored at 220uC until
Helicobacter Pylori and cd+ T Lymphocytes
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Rad, Hercules, CA), according to manufacturer’s instructions
using the human 27-plex panel. The following soluble proteins
were quantified: IL-1b, IL-1ra, IL-2, IL-4, IL-6, IL-8, IL-10, IL-
12p70, IL-13, IL-15, IL-17, eotaxin, basic fibroblast growth factor,
G-CSF, GM-CSF, IFN-c, IP-10, MCP-1 (CCL2), MIP-1a
(CCL3), MIP-1b (CCL4), PDGF, RANTES (CCL5), TNF-a,
and vascular endothelial growth factor.
Statistical Analysis
Statistical analysis was done by the paired Student’s paired T
test with a two-tailed distribution.
Supporting Information
Figure S1 CD3+ cells from peripheral blood of H. pylori-positive
(n=3) donors produce cytokines and chemokines comparable to
H. pylori-negative subjects (n=4) (A). Culture supernatants was
collected after 4 h of co-culture with H. pylori and analyzed by
bioplex assay. Data represent the means and the range of cytokines
and chemokines produced by T cells. No increase in cytokine and
chemokine production was observed with PBMCs from H. pylori-
positive subjects compared to the H. pylori negative. Note: n.d =
not detectable. B. The percentage of CD69 up-regulation induced
by viable H. pylori on CD3+ T cells is comparable in H. pylori-
positive and H. pylori-negative subjects. Purified CD3+ cells were
co-cultured with H. pylori (MOI 100). After 18 h cells were stained
with anti CD3-PB and anti-CD69-APC. Numbers represent the
percentage of CD3+CD69+ cells. The average was calculated
from three independent experiments.
(TIFF)
Figure S2 H. pylori DVacA activate CD3+ T cells in a non-
antigen-specific fashion after 16 hours of co-culture by inducing
IFN-c production. No differences have been found between G27
wild type and H. pylori VacA knockout mutant, suggesting that
VacA is not involved in this activation mechanism. On the
contrary, in the presence of the mutant DCagA a reduction of
IFN-c production was observed. Data are representative of two
independent experiments with similar results. The numbers in
each panel represent the percentage of IFN-c-producing CD3+
cells.
(TIFF)
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